Search Results - "S. LAVAU-DENES"

Incidence and associated factors of cetuximab-induced hypersensitivity infusion reactions in 1392 cancer patients treated in four French areas: a possible association with Lyme disease? by Dupont, M, Carlier, Claire, Gower-Rousseau, C, Barbier-Lider, P, Botsen, D, Brasseur, M, Burgevin, A, Chourbagi, C, D'Almeida, R, Hautefeuille, V, Hentzien, M, Lambert, A, Lamuraglia, M, Lavau-Denes, S, Lopez, A, Parent, D, Slimano, F, Brugel, M, Bouché, O

“…Previous studies have observed an increased incidence of Cetuximab-induced hypersensitivity infusion reactions (CI-IRs) in the southeastern states of the USA…”
Get full text

Cetuximab, topotecan and cisplatin for the treatment of advanced cervical cancer: A phase II GINECO trial by Kurtz, J.E, Hardy-Bessard, A.-C, Deslandres, M, Lavau-Denes, S, Largillier, R, Roemer-Becuwe, C, Weber, B, Guillemet, C, Paraiso, D, Pujade-Lauraine, E

“…Abstract Objective c isplatin (Cp) plus topotecan (Tc) is the first combination chemotherapy to demonstrate a survival advantage over cisplatin alone in…”
Get full text

Chemotherapy Response Evaluation in Metastatic Colorectal Cancer with FDG PET/CT and CT Scans by J. MONTEIL, N. MAHMOUDI, S. LEOBON, P.Y. ROUDAUT, A. EL BADAOUI, S. VERBEKE, L. VENAT-BOUVET, J. MARTIN, V. LE BRUN-LY, S. LAVAU-DENES, A. MAUBON, P. BOUILLET, M. POUQUET, J.C. VANDROUX, N. TUBIANA-MATHIEU

“…Background: [18F]-fluorodeoxyglucose with positron-emission tomography (PET) and computed tomography (CT) scans were used to assess morphological and metabolic…”
Get full text

Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial—PRODIGE 20 study results by Aparicio, T., Bouché, O., Taieb, J., Maillard, E., Kirscher, S., Etienne, P.-L., Faroux, R., Khemissa Akouz, F., El Hajbi, F., Locher, C., Rinaldi, Y., Lecomte, T., Lavau-Denes, S., Baconnier, M., Oden-Gangloff, A., Genet, D., Paillaud, E., Retornaz, F., François, E., Bedenne, L.

“…Metastatic colorectal cancer frequently occurs in elderly patients. Bevacizumab in combination with front line chemotherapy (CT) is a standard treatment but…”
Get full text

Geriatric analysis from PRODIGE 20 randomized phase II trial evaluating bevacizumab + chemotherapy versus chemotherapy alone in older patients with untreated metastatic colorectal cancer by Aparicio, T., Bouché, O., Francois, E., Retornaz, F., Barbier, E., Taieb, J., Kirscher, S., Etienne, P.-L., Faroux, R., Khemissa Akouz, F., El Hajbi, F., Locher, C., Rinaldi, Y., Lecomte, T., Lavau-Denes, S., Baconnier, M., Oden-Gangloff, A., Genet, D., Bedenne, L., Paillaud, E., Zawadi, Mohamed-Ayman, Volet, Julien, Cavaglione, Gérard, Lepere, Céline, Rougier, Philippe, Zaanan, Aziz, Besson, Dominique, Fawzi, Kara Slimane, Adenis, Antoine, Gatineau-Sailliant, Gilles, Brezault, Catherine, Coriat, Romain, Tougeron, David, Hautefeuille, Vincent, Chone, Laurence, Molin, Yann, Seitz, Jean-François, Le Tallec, Véronique Jestin, Ben Abdelghani, Meher, Villing, Anne-Laure, Aouakli, Amar, Sebbagh, Virginie, Bedjaoui, Ahmed, Mitry, Emmanuel, Carola, Elisabeth, Boulat, Olivier, Queuniet, Anne-Marie, Capitain, Olivier, Jouve, Jean-Louis, Baumgaertner, Isabelle, Almaric, Françoise, Bonnetain, Franck, Subtil, Fabien

“…Older patients have frailty characteristics that impair the transposition of treatment results found in younger patients. Predictive factors are needed to help…”
Get full text

A phase III trial of exemestane plus bevacizumab maintenance therapy in patients with metastatic breast cancer after first-line taxane and bevacizumab: a GINECO group study by Trédan, O., Follana, P., Moullet, I., Cropet, C., Trager-Maury, S., Dauba, J., Lavau-Denes, S., Diéras, V., Béal-Ardisson, D., Gouttebel, M., Orfeuvre, H., Stefani, L., Jouannaud, C., Bürki, F., Petit, T., Guardiola, E., Becuwe, C., Blot, E., Pujade-Lauraine, E., Bachelot, T.

“…Maintenance strategies beyond response or tumor stabilization with first-line chemotherapy in metastatic breast cancer (MBC) have not been extensively studied…”
Get full text

Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial-PRODIGE 20 study results by Aparicio, T, Bouché, O, Taieb, J, Maillard, E, Kirscher, S, Etienne, P -L, Faroux, R, Khemissa Akouz, F, El Hajbi, F, Locher, C, Rinaldi, Y, Lecomte, T, Lavau-Denes, S, Baconnier, M, Oden-Gangloff, A, Genet, D, Paillaud, E, Retornaz, F, François, E, Bedenne, L

Get full text

Effects of a home-based walking training program on cardiorespiratory fitness in breast cancer patients receiving adjuvant chemotherapy: a pilot study by Vincent, F, Labourey, J L, Leobon, S, Antonini, M T, Lavau-Denes, S, Tubiana-Mathieu, N

“…Breast cancer treatment is associated with a decline in measured cardiorespiratory fitness and increased fatigue. There is accumulating evidence that exercise…”
Get more information

ONCOGRAM: study protocol for the evaluation of therapeutic response and survival of metastatic colorectal cancer patients treated according to the guidelines of a chemosensitivity assay, the Oncogramme by Mathonnet, Muriel, Vanderstraete, Mathieu, Bounaix Morand du Puch, Christophe, Giraud, Stéphanie, Lautrette, Christophe, Ouaissi, Mehdi, Tabchouri, Nicolas, Taïbi, Abdelkader, Martin, Renaud, Herafa, Isabelle, Tchalla, Achille, Christou, Niki

“…Colorectal cancer is a major public concern, being the second deadliest cancer in the world. Whereas survival is high for localized forms, metastatic…”
Get full text

Pharmacokinetics and exposure–effect relationships of capecitabine in elderly patients with breast or colorectal cancer by Daher Abdi, Z., Lavau-Denes, S., Prémaud, A., Urien, S., Sauvage, F. L., Martin, J., Leobon, S., Marquet, P., Tubiana-Mathieu, N., Rousseau, A.

“…Purpose The aims of the present study were (1) to investigate the impact of great age on pharmacokinetics of capecitabine and its metabolites and (2) to…”
Get full text

SUN-LB280: Double Blind Multicenter Phase III Gortec Trial Evaluating the Efficacy of Oral Immune Modulating Formulae Therapy During Adjuvant Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma (HNSCC) by Senesse, P.F, Graff-Cailleaud, P, Sire, C, Gallocher, O, Lavau-Denes, S, Garcia-Ramirez, M, Alfonsi, M, Cupissol, D, Kaminsky, M.-C, Fiore, S, Flori, N, de Forges, H, Garrel, R, Janiszewski, C, Thézénas, S, Boisselier, P

Get full text

Pre-irradiation Chemotherapy for Newly Diagnosed High Grade Astrocytoma by TUBIANA MATHIEU, N, GENET, D, LABROUSSE, F, BOUILLET, P, LAVAU DENES, S, MARTIN, J, LABOUREY, J. L, VENAT, L, CLAVERE, P, MOREAU, J. J

“…The purpose of this work was to determine the response rate and toxicity of a combination of Carmustine and Cisplatin administered before radiation in patients…”
Get full text

PP111-SUN THE EFFECTS OF NUTRITIONAL ADVICES IN OLDER PATIENTS AT RISK FOR MALNUTRITION DURING CHEMOTHERAPY FOR CANCER ON THE QUALITY OF INTAKES. MULTICENTRE INOGAD STUDY by Bourdel-Marchasson, I, Durrieu, J, Doussau, A, Germain, C, Blanc, J.-F, Lahmar, C, Dauba, J, Terrebonne, E, Lécaille, C, Ceccaldi, J, Cany, L, Lavau-Denes, S, Houdé, N, Chomy, F, Soubeyran, P, Blanc-Bisson, C, Fonck, M

Get full text

5190 POSTER Feasibility of Home-adapted Aerobic Exercise Training on Peak Oxygen Consumption and Fatigue in Breast Cancer Patients During Adjuvant Chemotherapy by Vincent, F, Labourey, J.L, Leobon, S, Antonini, M.T, Cornette, T, Lemaire, F, Venat-Bouvet, L, Lavau-Denes, S, Preux, P.M, Tubiana-Mathieu, N

Get full text

Nutritional Advices in Older Patients at Risk for Malnutrition During Chemotherapy for Cancer: No Effect on Mortality Decreased Rate or Severe Infections. Multicentre Inogad Study by Bourdel-Marchasson, I, Durrieu, J, Doussau, A, Germain, C, Blanc, J.-F, Lahmar, C, Dauba, J, Terrebonne, E, Lecaille, C, Ceccaldi, J, Cany, L, Lavau-Denes, S, Chomy, F, Houede, N, Soubeyran, P, Blanc-Bisson, C, Fonck, M

Get full text

Phase III trial of chemotherapy with or without irinotecan in the front-line treatment of metastatic colorectal cancer in elderly patients (FFCD 2001–02 trial). Results of a planned interim analysis by Mitry, E, Phelip, J.M, Bonnetain, F, Lavau Denes, S, Adhoute, X, Gasmi, M, Jouve, J.L, Khemissa, F, Lecomte, T, Aparicio, T

Get full text

OP037 NUTRITIONAL ADVICES IN OLDER PATIENTS AT RISK FOR MALNUTRITION DURING CHEMOTHERAPY FOR CANCER: NO EFFECT ON MORTALITY DECREASED RATE OF SEVERE INFECTIONS. MULTICENTRE INOGAD STUDY by Bourdel-Marchasson, I, Blanc-Bisson, C, Doussau, A, Germain, C, Blanc, J.F, Lahmar, C, Dauba, J, Terrebonne, E, Lecaille, C, Ceccaldi, J, Cany, L, Lavau-Denes, S, Houede, N, Chomy, F, Durrieu, J, Fonck, M

Get full text

175P Prosigna test for early breast cancer patients in real-life by Hequet, D., Rouzier, R., Lerebours, F., Menet, E., Dalenc, F., Nicolai, V., Hajjaji, N., Lavau-Denes, S., Fermeaux, V., Texier, L., Cayre, A., Jauffret, E. Charafe, Boucrauta, A., Tredan, O., Lopez, J.

Get full text

Nutritional advice in older patients at risk of malnutrition during treatment for chemotherapy: a two-year randomized controlled trial by Bourdel-Marchasson, Isabelle, Blanc-Bisson, Christelle, Doussau, Adélaïde, Germain, Christine, Blanc, Jean-Frédéric, Dauba, Jérôme, Lahmar, Cyril, Terrebonne, Eric, Lecaille, Cédric, Ceccaldi, Joël, Cany, Laurent, Lavau-Denes, Sandrine, Houede, Nadine, Chomy, François, Durrieu, Jessica, Soubeyran, Pierre, Senesse, Pierre, Chene, Geneviève, Fonck, Mariane

“…We tested the effect of dietary advice dedicated to increase intake in older patients at risk for malnutrition during chemotherapy, versus usual care, on…”
Get full text

CN46 Real-life experience of nurses coordinating device in oral therapy center (DICTO program) by Deluche, E., Darbas, T., Bourcier, K., Montangon, L., Lebrun, V. Ly, Pestre, J., Venat, L., Thuillier, F., Nevado, E., Maillan, G., Bayard, G., Caille, E., Chaput, S., Querrioux, J., Suchaud, C., Zabaleta, S., Leobon, S., Tubiana-Mathieu, N., Lavau-Denes, S.

Get full text